Literature DB >> 17317262

Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE.

Mark E Wickham1, Claudia Lupp, Alejandra Vázquez, Mariola Mascarenhas, Bryan Coburn, Brian K Coombes, Mohamed A Karmali, José L Puente, Wanyin Deng, B Brett Finlay.   

Abstract

Severe disease caused by Shiga toxin-producing Escherichia coli (STEC) has been associated with a pathogenicity island, O-Island 122, which encodes the type III secretion system-effector NleE. Here we show that full virulence of the related attaching and effacing mouse pathogen Citrobacter rodentium requires NleE. Relative to wild-type bacteria, nleE-mutant C. rodentium are attenuated for colonisation in mice in both single and mixed infections. Examination of the ability of nleE-mutant bacteria to induce pathologic change in vivo revealed that nleE-mutant bacteria induce significantly less pathologic change than wild-type bacteria in susceptible mice. Consistent with these results, mice infected with nleE-mutant bacteria exhibit delayed mortality. These results suggested that pathologic change during attaching and effacing pathogen infection may associate with the degree of pathogen colonisation. Using mutants of 23 type III secretion genes, including the type III effectors nleC, nleD, nleE and nleF, the association of pathologic change with the ability of these mutants to colonise mice was examined. The induction of in vivo disease correlates strongly with the degree of colonisation, suggesting that the colonisation advantage type III secretion genes afford the bacteria, contribute to, and are required for, full virulence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317262     DOI: 10.1016/j.micinf.2006.12.016

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  21 in total

1.  A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli.

Authors:  Víctor A García-Angulo; Verónica I Martínez-Santos; Tomás Villaseñor; Francisco J Santana; Alejandro Huerta-Saquero; Luary C Martínez; Rafael Jiménez; Cristina Lara-Ochoa; Juan Téllez-Sosa; Víctor H Bustamante; José L Puente
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

2.  Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ.

Authors:  Ying Zhang; Sabrina Mühlen; Clare V Oates; Jaclyn S Pearson; Elizabeth L Hartland
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

3.  Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.

Authors:  Ho Pan Sham; Stephanie R Shames; Matthew A Croxen; Caixia Ma; Justin M Chan; Mohammed A Khan; Mark E Wickham; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2011-07-11       Impact factor: 3.441

4.  Role of inflammasomes in host defense against Citrobacter rodentium infection.

Authors:  Zhiping Liu; Md Hasan Zaki; Peter Vogel; Prajwal Gurung; B Brett Finlay; Wanyin Deng; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

5.  The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.

Authors:  Daniel V Zurawski; Karen L Mumy; Luminita Badea; Julia A Prentice; Elizabeth L Hartland; Beth A McCormick; Anthony T Maurelli
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

6.  Role of RpoS in the virulence of Citrobacter rodentium.

Authors:  Tao Dong; Brian K Coombes; Herb E Schellhorn
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

7.  The type III secretion effector NleE inhibits NF-kappaB activation.

Authors:  Chen Nadler; Kobi Baruch; Simi Kobi; Erez Mills; Gili Haviv; Marganit Farago; Irit Alkalay; Sina Bartfeld; Thomas F Meyer; Yinon Ben-Neriah; Ilan Rosenshine
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

8.  The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.

Authors:  Hayley J Newton; Jaclyn S Pearson; Luminita Badea; Michelle Kelly; Mark Lucas; Gavan Holloway; Kylie M Wagstaff; Michelle A Dunstone; Joan Sloan; James C Whisstock; James B Kaper; Roy M Robins-Browne; David A Jans; Gad Frankel; Alan D Phillips; Barbara S Coulson; Elizabeth L Hartland
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

9.  Characterization of the NleF effector protein from attaching and effacing bacterial pathogens.

Authors:  Frank Echtenkamp; Wanyin Deng; Mark E Wickham; Alejandra Vazquez; Jose L Puente; Ajitha Thanabalasuriar; Samantha Gruenheid; B Brett Finlay; Philip R Hardwidge
Journal:  FEMS Microbiol Lett       Date:  2008-04       Impact factor: 2.742

10.  NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation.

Authors:  Xiaofei Gao; Xiaogang Wang; Thanh H Pham; Leigh Ann Feuerbacher; Marie-Luise Lubos; Minzhao Huang; Rachel Olsen; Arcady Mushegian; Chad Slawson; Philip R Hardwidge
Journal:  Cell Host Microbe       Date:  2013-01-16       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.